Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Beyond Scalp: New study Suggests Role for Elissara® in Hair Growth
1+ week, 4+ day ago (244+ words) 01 Sep, 2026, 14:00 IDT Preclinical findings demonstrate nutricosmetic by Monteloeder may offer broad support to hair resilience MADRID, Sept. 1, 2026 /PRNewswire/ -- Results of a new study show that Elissara®, a nutricosmetic by Monteloeder, SL, a subsidiary of SuanNutra, SA, exhibits multifactorial activity associated…...
I tested the viral "as good as minoxidil" Mielle rosemary oil for 3 months. Here's what happened.
1+ mon, 2+ week ago (1660+ words) "I never wear my hair down because it has no volume."That's how our tester described her hair before trying Mielle Rosemary Mint Hair Oil: thinning all over, a skimpy ponytail, less body and the kind of diffuse shedding that…...
Why Do Some People Have A Widow’s Peak Hairline? An Evolutionary Biologist Explains
1+ mon, 2+ week ago (523+ words) Most people’s hairlines run more or less straight across the forehead. In some people, the hair dips down in the middle to form a distinct V, often called the widow’s peak. It’s one of the few human traits that almost…...
Veradermics' Oral Hair Loss Drug for Women Shows Results In Just 2 Months
1+ mon, 3+ week ago (43+ words) Veradermics Incorporated on Wednesday released topline results from an open-label Phase 2 trial evaluating its experimental VDPHL01 in women with mild-to-moderate pattern hair loss. The company said the treatment produced consistent hair growth, demonstrated an early onset of activity, and......
Veradermics Reports Positive Phase 2 Hair Loss Drug Trial Results
1+ mon, 3+ week ago (337+ words) Veradermics Incorporated announced on Wednesday positive topline results from an open-label Phase 2 clinical trial evaluating its experimental oral therapy, VDPHL01, for women experiencing mild-to-moderate pattern hair loss. As reported by Detik Finance, the biotechnology firm stated that the treatment demonstrated consistent…...
Veradermics keeps ‘momentum going’ as baldness drug helps women with hair loss
1+ mon, 3+ week ago (396+ words) The Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss. The results exceeded investor expectations and built on a…...
Veradermics stock jumps again on female hair loss drug win
1+ mon, 3+ week ago (506+ words) This is the second positive Phase II readout of VDPHL01, which analysts note could represent a $2bn+ market opportunity Veradermics has seen another jump in its stock price as its hair loss drug showed benefit in women with androgenetic alopecia (AGA). Patients…...
Veradermics stock jumps on encouraging data for oral hair loss option in women
1+ mon, 4+ week ago (15+ words) FirstWord PHARMA...
MANE: VDPHL01 Phase 2 data in women showed strong efficacy, rapid onset, and favorable safety — TradingView News
1+ mon, 4+ week ago (92+ words) MANE: VDPHL01 Phase 2 data in women showed strong efficacy, rapid onset, and favorable safety TradingView MANE: VDPHL01 Phase 2 data in women showed strong efficacy, rapid onset, and favorable safety Phase 2 open-label data for VDPHL01 in women with pattern hair loss showed robust hair…...
Veradermics reports phase 2 hair loss trial results By Investing.com
1+ mon, 4+ week ago (313+ words) Goldman Sachs flags fresh upside risks for oil as Gulf flows falter ASML, Inflation boost, Earnings roll on - What’s moving markets FREE WEBINAR: Investing.com experts unveil the top 10 ‘buy now’ picks for H2 2026 European chip stocks gain as ASML lifts…...